22 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
and surveillance to monitor the safety and efficacy of the products;
Elicio may decide to recall such products from the marketplace after they are approved … warning the public about safety issues with a product, refusal to permit the import or export of a product, product seizure, detention, or recall, operating
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
other things, voluntary recall and regulatory sanctions as described below.
The FDA also strictly regulates marketing, labeling, advertising
424B3
ELTX
Elicio Therapeutics Inc.
28 Apr 23
Prospectus supplement
4:07pm
the safety and efficacy of the products;
Elicio may decide to recall such products from the marketplace after they are approved;
Elicio could be sued … safety issues with a product, refusal to permit the import or export of a product, product seizure, detention, or recall, operating restrictions, civil
S-4/A
6p3zxz5ria6qbz6
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
10-Q
f44nrx6r6fmcai
17 May 21
Quarterly report
6:03am
10-K
qjj19g7ud
30 Mar 21
Annual report
5:00pm
424B4
tnnrb 8u0knicz7lka
5 Feb 21
Prospectus supplement with pricing info
5:12pm